Väänänen HK - Search Results

1

Serum osteocalcin is not associated with glucose but is inversely associated with leptin across generations of nondiabetic women.

Lu C, Ivaska KK, Alen M, Wang Q, Törmäkangas T, Xu L, Wiklund P, Mikkola TM, Pekkala S, Tian H, Väänänen HK, Cheng S. Lu C, et al. Among authors: vaananen hk. J Clin Endocrinol Metab. 2012 Nov;97(11):4106-14. doi: 10.1210/jc.2012-2045. Epub 2012 Sep 4. J Clin Endocrinol Metab. 2012. PMID: 22948754

2

Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).

Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Väänänen HK, Halleen JM. Alatalo SL, et al. Among authors: vaananen hk. Clin Chem. 2004 May;50(5):883-90. doi: 10.1373/clinchem.2003.029355. Epub 2004 Mar 11. Clin Chem. 2004. PMID: 15016726

3

Urinary osteocalcin as a marker of bone metabolism.

Ivaska KK, Käkönen SM, Gerdhem P, Obrant KJ, Pettersson K, Väänänen HK. Ivaska KK, et al. Among authors: vaananen hk. Clin Chem. 2005 Mar;51(3):618-28. doi: 10.1373/clinchem.2004.043901. Epub 2005 Jan 13. Clin Chem. 2005. PMID: 15650032

4

Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk.

Ivaska KK, Lenora J, Gerdhem P, Akesson K, Väänänen HK, Obrant KJ. Ivaska KK, et al. Among authors: vaananen hk. J Clin Endocrinol Metab. 2008 Jul;93(7):2622-32. doi: 10.1210/jc.2007-1508. Epub 2008 May 6. J Clin Endocrinol Metab. 2008. PMID: 18460567

5

Urinary osteocalcin and serum pro-C-type natriuretic peptide predict linear catch-up growth in infants.

Kilpeläinen L, Ivaska KK, Kuiri-Hänninen T, Väänänen HK, Rehfeld JF, Goetze JP, Sankilampi U, Dunkel L. Kilpeläinen L, et al. Among authors: vaananen hk. J Bone Miner Res. 2012 Jul;27(7):1528-35. doi: 10.1002/jbmr.1596. J Bone Miner Res. 2012. PMID: 22407446 Free article.

6

The effect of oral glucose tolerance test on serum osteocalcin and bone turnover markers in young adults.

Paldánius PM, Ivaska KK, Hovi P, Andersson S, Väänänen HK, Kajantie E, Mäkitie O. Paldánius PM, et al. Among authors: vaananen hk. Calcif Tissue Int. 2012 Feb;90(2):90-5. doi: 10.1007/s00223-011-9551-8. Epub 2011 Dec 8. Calcif Tissue Int. 2012. PMID: 22147278

7

Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy.

Ivaska KK, Pettersson K, Nenonen A, Uusi-Rasi K, Heinonen A, Kannus P, Väänänen HK. Ivaska KK, et al. Among authors: vaananen hk. Clin Chem. 2005 Dec;51(12):2362-5. doi: 10.1373/clinchem.2005.055541. Clin Chem. 2005. PMID: 16306097 Clinical Trial. No abstract available.

8

Identification of novel proteolytic forms of osteocalcin in human urine.

Ivaska KK, Hellman J, Likojärvi J, Käkönen SM, Gerdhem P, Akesson K, Obrant KJ, Pettersson K, Väänänen HK. Ivaska KK, et al. Among authors: vaananen hk. Biochem Biophys Res Commun. 2003 Jul 11;306(4):973-80. doi: 10.1016/s0006-291x(03)01093-3. Biochem Biophys Res Commun. 2003. PMID: 12821138

9

Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro.

Ivaska KK, Hentunen TA, Vääräniemi J, Ylipahkala H, Pettersson K, Väänänen HK. Ivaska KK, et al. Among authors: vaananen hk. J Biol Chem. 2004 Apr 30;279(18):18361-9. doi: 10.1074/jbc.M314324200. Epub 2004 Feb 16. J Biol Chem. 2004. PMID: 14970229 Free article.

10

Biochemical markers of bone turnover are influenced by recently sustained fracture.

Obrant KJ, Ivaska KK, Gerdhem P, Alatalo SL, Pettersson K, Väänänen HK. Obrant KJ, et al. Among authors: vaananen hk. Bone. 2005 May;36(5):786-92. doi: 10.1016/j.bone.2005.02.009. Epub 2005 Mar 31. Bone. 2005. PMID: 15804493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page